This week’s note is regarding the packaging of laboratory tests. This week’s note from the instructor is written by Valerie A. Rinkle, MPA, regulatory specialist for HCPro. Ms. Rinkle is new to the HCPro team, and a nationally recognized Medicare expert. For more information about this exciting addition to the HCPro team, click here.
This week’s updates include an update to the list of compendia for the determination of a “Medically-Accepted Indication” of drugs and biologicals used off-label in an anti-cancer chemotherapeutic regimen; a payment reduction for Computed Tomography (CT) diagnostic imaging services; and more!
The 2016 OPPS final rule certainly has some provisions that providers won’t be happy about, including a negative payment update for the first time, but CMS did provide some relief on what would surely be an onerous policy.
